Startups
Metaphore Biotechnologies is harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. The company’s MIMiC™ platform is a computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized. Metaphore is focused on making previously intractable drug targets accessible and unlocking breakthroughs that outperform today’s drugs for maximum patient impact. Metaphore was founded in 2021 in Flagship Labs, a unit of Flagship Pioneering.
Overview
Location
United States, Massachusetts, Cambridge
Employees
11-50
Total raised
$50M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 18, 2023 | Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry | Flagship Pioneering, the bioplatform innovation company, announced the launch of Metaphore Biotechnologies, a company harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional m... |
| May 16, 2023 | Metaphore Biotechnologies Raises USD50M in Funding | Metaphore Biotechnologies, a Cambridge, MA-based company which specializes in biomimicry and machine learning for molecular mimics, raised USD50M in funding. Flagship made the investment. The company intends to use the funds to advance its ... |
| Metaphore Biotechnologies | “Our MIMiC™ platform drives unprecedented insights into molecular interactions to design new molecules precisely tuned for therapeutic benefit.” | |
| Metaphore Biotechnologies: Bioplatform Innovation Company Secures $50 Million In Funding | Bioplatform innovation company Flagship Pioneering announced the launch of Metaphore Biotechnologies, a company harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecul... |
Reviews 0
FAQ about Metaphore Biotechnologies
How much funding has Metaphore Biotechnologies raised?
Metaphore Biotechnologies has raised $50M in total across 1 funding round.
What has the press written about Metaphore Biotechnologies?
Parsers VC has collected 5 articles mentioning Metaphore Biotechnologies, among them “Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry” (May 18, 2023) and “Metaphore Biotechnologies Raises USD50M in Funding” (May 16, 2023).
Is Metaphore Biotechnologies still active?
Yes, Metaphore Biotechnologies is active; its latest activity on Parsers VC dates from Aug 5, 2026.